Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials.

Huijuan CaoRuohan WuMei HanPatrina Ha Yuen CaldwellJian Ping Liu

Published in: PloS one (2017)

This review found very low-quality evidence that CHM prevented HDN caused by maternal-fetal ABO incompatibility. No firm conclusions can be drawn regarding the effectiveness or safety of CHM for this condition.

Keyphrases

randomized controlled trial
birth weight
preterm infants
systematic review
gestational age
pregnancy outcomes
quality improvement
weight gain
weight loss
preterm birth